Language

English

Publication Date

2-26-2026

Journal

Revista Colombiana de Psiquiatría

DOI

10.1016/j.rcp.2025.09.002

PMID

42746436

PMCID

PMC13577450

PubMedCentral® Posted Date

9-16-2026

PubMedCentral® Full Text Version

Author MSS

Abstract

Introduction: Obsessive compulsive disorder (OCD) affects about 1-2% of the global population, with roughly 30% of patients not responding to first-line treatments. Transcranial Magnetic Stimulation (TMS) has some support for treatment-resistant OCD but global use is unclear.

Methods: This study describes the frequency with which TMS was reported to be received among a large cohort of individuals who self-identified as Latino-Hispanic in Latin America and the United States. Among 3,391 participants, 76 (2.2%) had completed TMS for OCD.

Results: Recipients who received TMS exhibited more severe current and lifetime OCD symptoms compared to non-recipients. On average, participants underwent 22.61 TMS sessions (SD=20.96), and self-reported experiencing minimal to some improvement from TMS. The majority of TMS recipients were from Brazil (n=26), Mexico (n=17) and USA (n=16).

Conclusions: Findings suggest that TMS does not appear to be widely used in OCD treatment among the Latino-Hispanic population, particularly in Latin American countries. Further study of TMS efficacy and dissemination in underserved regions is warranted.

Keywords

Neuromodulation, Treatment, Anxiety, Latin-America, Brazil, Treatment-resistant

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.